Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 14, 2023, titled “Glenmark Pharmaceuticals receives ANDA approval for Clindamycin HydrochlorideCapsules USP, 75 mg, 150 mg, and 300……
| Subscribe To Our Free Newsletter |
